SERA vs. AUNA, DCGO, SBC, FLGT, INNV, CELC, EHAB, PSNL, AIRS, and VMD
Should you be buying Sera Prognostics stock or one of its competitors? The main competitors of Sera Prognostics include Auna (AUNA), DocGo (DCGO), SBC Medical Group (SBC), Fulgent Genetics (FLGT), InnovAge (INNV), Celcuity (CELC), Enhabit (EHAB), Personalis (PSNL), AirSculpt Technologies (AIRS), and Viemed Healthcare (VMD). These companies are all part of the "healthcare" industry.
Sera Prognostics vs.
Sera Prognostics (NASDAQ:SERA) and Auna (NYSE:AUNA) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, community ranking, risk, dividends, analyst recommendations, profitability, institutional ownership, media sentiment and earnings.
Sera Prognostics has higher earnings, but lower revenue than Auna.
Auna has a consensus price target of $13.53, indicating a potential upside of 53.61%. Given Auna's higher possible upside, analysts plainly believe Auna is more favorable than Sera Prognostics.
In the previous week, Auna had 1 more articles in the media than Sera Prognostics. MarketBeat recorded 7 mentions for Auna and 6 mentions for Sera Prognostics. Auna's average media sentiment score of 0.57 beat Sera Prognostics' score of -0.07 indicating that Auna is being referred to more favorably in the news media.
54.6% of Sera Prognostics shares are held by institutional investors. 15.8% of Sera Prognostics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.
Sera Prognostics received 3 more outperform votes than Auna when rated by MarketBeat users. However, 100.00% of users gave Auna an outperform vote while only 38.46% of users gave Sera Prognostics an outperform vote.
Auna's return on equity of 0.00% beat Sera Prognostics' return on equity.
Summary
Auna beats Sera Prognostics on 8 of the 13 factors compared between the two stocks.
Get Sera Prognostics News Delivered to You Automatically
Sign up to receive the latest news and ratings for SERA and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Sera Prognostics Competitors List
Related Companies and Tools
This page (NASDAQ:SERA) was last updated on 2/18/2025 by MarketBeat.com Staff
